European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly summary in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status

Include:

Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:

/

Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Abseamed

epoetin alfa

Anemia Cancer Kidney Failure, Chronic 28/08/2007           Authorised
Alpheon

recombinant human interferon alfa-2a

Hepatitis C, Chronic 05/09/2006           Refused
Bemfola

follitropin alfa

Anovulation 27/03/2014           Authorised
Binocrit

epoetin alfa

Anemia Kidney Failure, Chronic 28/08/2007           Authorised
Biograstim

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 15/09/2008           Authorised
Epoetin Alfa Hexal

epoetin alfa

Anemia Cancer Kidney Failure, Chronic 28/08/2007           Authorised
Filgrastim Hexal

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 06/02/2009           Authorised
Filgrastim ratiopharm

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 15/09/2008           Withdrawn
Grastofil

filgrastim

Neutropenia 18/10/2013           Authorised
Inflectra

infliximab

Arthritis, Psoriatic Arthritis, Rheumatoid Colitis, Ulcerative Crohn Disease Psoriasis Spondylitis, Ankylosing 10/09/2013           Authorised
Nivestim

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 08/06/2010           Authorised
Omnitrope

somatropin

Dwarfism, Pituitary Prader-Willi Syndrome Turner Syndrome 12/04/2006           Authorised
Ovaleap

follitropin alfa

Anovulation 27/09/2013           Authorised
Ratiograstim

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 15/09/2008           Authorised
Remsima

infliximab

Arthritis, Psoriatic Arthritis, Rheumatoid Colitis, Ulcerative Crohn Disease Psoriasis Spondylitis, Ankylosing 10/09/2013           Authorised
Retacrit

epoetin zeta

Anemia Blood Transfusion, Autologous Cancer Kidney Failure, Chronic 18/12/2007           Authorised
Silapo

epoetin zeta

Anemia Blood Transfusion, Autologous Cancer Kidney Failure, Chronic 18/12/2007           Authorised
Tevagrastim

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 15/09/2008           Authorised
Valtropin

somatropin

Dwarfism, Pituitary Turner Syndrome 24/04/2006           Withdrawn
Zarzio

filgrastim

Cancer Hematopoietic Stem Cell Transplantation Neutropenia 06/02/2009           Authorised